| Larry L Washburn, OD | |
|
505 N Franklin Ave, Ste B, Colby, KS 67701-2356 | |
| (785) 462-3348 | |
| (785) 462-3599 |
| Full Name | Larry L Washburn |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 505 N Franklin Ave, Colby, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265629729 | NPI | - | NPPES |
| 100090170A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1111-3 (Kansas) | Primary |
| Provider Name | Sam R Funk Od Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467568519 PECOS PAC ID: 1254638000 Enrollment ID: O20160323000463 |
News Archive
A multinational research team led by scientists at the National Institutes of Health has found that a genetic variant of a brain receptor molecule may contribute to violently impulsive behavior when people who carry it are under the influence of alcohol.
Two major insurers - Anthem Blue Cross and Blue Shield of California - are creating a joint health-information exchange, making the medical records of about nine million plan members available to participating doctors and hospitals.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Nearly 55 percent of U.S. infants are placed to sleep with bedding that increases the risk of sudden infant death syndrome, or SIDS, despite recommendations against the practice, report researchers at the National Institutes of Health, the Centers for Disease Control and Prevention, and other institutions.
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larry L Washburn, OD Po Box 747, 505 N Franklin Ave, Colby, KS 67701-0747 Ph: (785) 462-3348 | Larry L Washburn, OD 505 N Franklin Ave, Ste B, Colby, KS 67701-2356 Ph: (785) 462-3348 |
News Archive
A multinational research team led by scientists at the National Institutes of Health has found that a genetic variant of a brain receptor molecule may contribute to violently impulsive behavior when people who carry it are under the influence of alcohol.
Two major insurers - Anthem Blue Cross and Blue Shield of California - are creating a joint health-information exchange, making the medical records of about nine million plan members available to participating doctors and hospitals.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Nearly 55 percent of U.S. infants are placed to sleep with bedding that increases the risk of sudden infant death syndrome, or SIDS, despite recommendations against the practice, report researchers at the National Institutes of Health, the Centers for Disease Control and Prevention, and other institutions.
Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.
› Verified 8 days ago
Dr. Jordan D Hagler, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1005 S Range Ave, Ste 100, Colby, KS 67701 Phone: 785-462-8231 Fax: 785-462-2307 | |
Dr. Andrea Lynn Hagler, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1005 S Range Ave, Ste 100, Colby, KS 67701 Phone: 785-462-8231 Fax: 785-462-2307 | |
Sam R. Funk, O.d., P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 505 N Franklin Ave Ste B, Colby, KS 67701 Phone: 785-462-3348 Fax: 785-462-3599 | |
Dr. Jeffrey B Morrison, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1005 S Range Ave, Ste 100, Colby, KS 67701 Phone: 785-462-8231 Fax: 785-462-2307 | |
Dr. Sam Rodger Funk, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 505 N Franklin Ave Ste B, Colby, KS 67701 Phone: 785-462-3348 Fax: 785-462-3599 |